Colorado Medical Board
Medical Frequently Asked Questions
Information about the Medical Board including licensure, the Healthcare Professions Profile Program, and much more.
Read more about
Medical Frequently Asked Questions
0
  1. Home
  2. DPO Home
  3. Medical HOME

Medical HOME

#FFFFFF

Welcome to the Medical Homepage

The Colorado Medical Board (CMB) was instituted as part of the Medical Practice Act for the purpose of regulating and controlling the practice of healing arts, which include establishing and enforcing the licensing standards for Medical Doctors (M.D.s), Doctors of Osteopathy (D.O.s), Physician Assistants (P.A.s), and Anesthesiology Assistants (A.A.s). Licensure is mandatory to practice medicine in Colorado or to treat Colorado patients. Exceptions exist for the Veterans Administration, Bureau of Indian Affairs, and Department of Defense physicians and other licensed healthcare providers.

The CMB investigates the unlicensed practice of medicine, however, it does not have authority to arbitrate or adjudicate fee disputes. The decisions made by the CMB are not subject to administrative review. The CMB is a Type I Board, meaning that it is policy autonomous and comprised of professional and public members (eight M.D.s, three D.O.s, two P.A.s, and four public members).

Program Information

Program/Board Members

Paula E. Martinez, Program Director

Colorado Medical Board 
1560 Broadway, Suite 1350
Denver, CO 80202

Phone: 303-894-7800  |  Fax: 303-894-7692  |  Email: dora_medicalboard@state.co.us

Roland Flores, Jr., M.D., President
Professional Member | Term Expires: May 3, 2023

Panel A:

  • Amanda Mixon, P.A.-C, Panel A Chair
    Professional Member | Term Expires: May 3, 2024

  • Jennifer Blair, M.D.
    Professional Member | Term Expires: May 3, 2025

  • Beckett Czarnecki
    Public Member | Term Expires: May 3, 2026

  • Robert M. Maulitz, M.D.
    Professional Member | Term Expires: May 3, 2025

  • Saughar Samali, D.O.
    Professional Member | Term Expires: May 3, 2024

  • Alan E. Shackelford, M.D.
    Professional Member | Term Expires: May 3, 2023

Panel B:

  • Kiely M. Schultz, D.O., Panel B Chair
    Professional Member | Term Expires: May 3, 2026

  • Amy E. Colen, Panel B Vice President
    Public Member | Term Expires: May 3, 2023

  • Anita Kumar, M.D.
    Professional Member | Term Expires: May 3, 2026

  • Donald J. Lefkowits, M.D.
    Professional Member | Term Expires: May 3, 2023

  • Maidul (May) Mehmud
    Public Member | Term Expires: May 3, 2026

  • Kian A. Modanlou, M.D.
    Professional Member | Term Expires: May 3, 2024

Licensing Panel

  • Scott C. Strauss, D.O., FAAFP, Licensing Panel Chair
    Professional Member | Term Expires: May 3, 2025

  • Christopher A. Bates, M.D.
    Professional Member | Term Expires: May 3, 2025

  • Julie Ann Harper, P.A.-C
    Professional Member | Term Expires: May 3, 2025

  • Hien (Adam) H. Ly
    Public Member | Term Expires: May 3, 2024

Public Notices

Permanent Rulemaking Hearing - November 17, 2022

The Colorado Medical Board will hold a Permanent Rulemaking Hearing to allow stakeholders a final opportunity to provide testimony before the Board considers adopting multiple proposed new and revised rules to implement Colorado Senate Bill 22-116 (Concerning the ability of an individual to obtain an occupational credential through the occupational credential portability program); Colorado House Bill 22-1115 (Concerning the Prescription Drug Monitoring Program); Colorado House Bill 22-1284 (Concerning updates to state surprise billing laws to facilitate the implementation of surprise billing protections, and aligning state law with the federal "No Surprises Act"); Executive Order D 2022-032 (Directing State Agencies to Protect Access to Reproductive Health Care in Colorado); and Executive Order D 2022-034 (Protecting Colorado’s Workforce and Expanding Licensing Opportunities). 

 

Emergency Rulemaking Hearing - October 6, 2022

The Colorado Medical Board will hold an Emergency Rulemaking Hearing to allow stakeholders a final opportunity to provide testimony before the Board considers adopting new Rules 161 (3 CCR 713-51) and 162 (3 CCR 713-52), to implement Executive Order D 2022-032 (Directing State Agencies to Protect Access to Reproductive Health Care in Colorado); and Executive Order D 2022-034 (Protecting Colorado’s Workforce and Expanding Licensing Opportunities). The Board will consider emergency adoption of Rules 161 (3 CCR 713-51) and 162 (3 CCR 713-52) to comply with the reporting requirements of the Executive Orders.

Stakeholder Meeting - May 19, 2022

The Colorado Medical Board will hold a Permanent Rulemaking Hearing to allow stakeholders a final opportunity to provide testimony before the Board considers adopting the proposed revisions to Rules 130 (3 CCR 713-28), 410 (3 CCR 713-29), and 520 (3 CCR 713-42), to implement Colorado House Bill 20-1326 (Concerning an expansion of an individual's ability to practice an occupation in Colorado through creation of an occupational credential portability program).

 

Permanent Rulemaking Hearing - February 17, 2022

The Colorado Medical Board held a Permanent Rulemaking Hearing on February 17, 2022, that allowed stakeholders a final opportunity to provide testimony before the Board considered adopting the proposed revisions to Rule 120 (3 CCR 713-22), to implement Colorado House Bill 20-1326 (Concerning an expansion of an individual's ability to practice an occupation in Colorado through creation of an occupational credential portability program).

 

Joint Stakeholder Meeting - February 14, 2022

The State Board of Pharmacy (Board) held a Joint Stakeholder Meeting that allowed stakeholders from the State Board of Pharmacy, Colorado Medical Board, and State Board of Nursing an opportunity to provide feedback on the proposed revisions to the Statewide Protocol for Prescribing Hormonal Contraceptive Patches and Oral Contraceptives (Appendix A), and the Colorado Self-Screening Contraception Risk Assessment Questionnaire to include Vaginal Rings and Depot Medroxyprogesterone Acetate (DPMA). Additionally, updates to the Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use, embedded in Appendix A of the Board’s rules, are proposed to align the rules with recent updates from the Centers for Disease Control and Prevention (CDC).

 

Stakeholder Meeting - January 7, 2022

The Colorado Medical Board held a virtual Stakeholder Meeting on January 7, 2022, that allowed stakeholders an opportunity to provide feedback on the implementation of Colorado House Bill 20-1326 (Concerning an expansion of an individual's ability to practice an occupation in Colorado through creation of an occupational credential portability program); and the subsequent proposed revisions to Rules 120 (3 CCR 713-22), 130 (3 CCR 713-28), 410 (3 CCR 713-29), and 520 (3 CCR 713-42).

 

Permanent Rulemaking Hearing - May 20, 2021

The Colorado Medical Board held a Permanent Rulemaking Hearing that allowed stakeholders a final opportunity to provide feedback before the Board considered adopting revisions to Rule 170, to correct language in the rule that conflicted with portions of the statute in section 12-30-115, C.R.S., of Colorado Senate Bill 20-102 (Concerning required disclosures to patients regarding formal actions based on sexual misconduct)

 

Permanent and Emergency Rulemaking Hearing - November 18, 2021

The Colorado Medical Board held a Permanent and Emergency Rulemaking Hearing on November 18, 2021, that allowed stakeholders a final opportunity to provide testimony on the implementation of Colorado House Bill 20-1326 (Concerning an expansion of an individual's ability to practice an occupation in Colorado through creation of an occupational credential portability program); Colorado House Bill 21-1276 (Concerning the prevention of substance use disorders); and the subsequent proposed revisions to Rule 120 (3 CCR 713-22) to implement HB20-1326, and the proposed new rule (3 CCR 713-49) to implement HB21-1276 - which will be considered for permanent and emergency adoption to comply with the legislative mandate. The Board did not adopt revisions to Rule 120 (3 CCR 713-22) during this hearing, those revisions will be considered at the next Board Meeting on February 17, 2022.

 

Joint Stakeholder Meeting - October 15, 2021

The State Board of Pharmacy, State Board of Nursing, Colorado Medical Board, Colorado Dental Board, Colorado Podiatry Board, State Board of Veterinary Medicine, and State Board of Optometry held a Joint Stakeholder Meeting to gather feedback to identify and create a list of prescription drugs and substances (using evidence-based practices), in addition to controlled substances, that have a substantial potential for abuse and must require pharmacists and prescription drug outlets to report those prescription drugs and substances to the Prescription Drug Monitoring Program (PDMP) when dispensed to a patient. The Board is considering the development of new rules to monitor non-controlled prescription drugs/substances, as allowed per section 12-280-404(2)(b)(I), C.R.S., of Colorado Senate Bill 21-098.

Legislative Updates
Meeting Minutes

Full Board Meeting Minutes

Licensing Panel Meeting Minutes

Open Embed